Skip to content

Opko Health OPK Pharmaceutical — Segment Reporting Other Item Amount

Other segment segments

Diagnostics
-$18.07M

Similar metrics at other companies

AMP
AMPHPharmaceutical Products — Segment Reporting Other Item Amount
$55.01M+40.1%
Disc Medicine logo
IRONOther Segment Items — Segment Reporting Other Item Amount
$6.02M+2.7%
Worthington Enterprises logo
WORConsumer Products — Segment Reporting Other Item Amount
-$25K-308%
CryoPort, Inc. logo
CYRXLife Sciences Products — Segment Reporting Other Item Amount
$1.48M+34.2%
Gray Television logo
GTNAll Other Segments — Segment Reporting Other Item Amount
$19M+35.7%
Nektar Therapeutics logo
NKTRAll Other Segments — Segment Reporting Other Item Amount
$4.27M-4.2%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$921.21M-14.0%
P/S1.6×0.0×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: Opko Health’s 10-Q, filed July 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's pharmaceutical — segment reporting other item amount.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's pharmaceutical — segment reporting other item amount?
Opko Health (OPK) reported pharmaceutical — segment reporting other item amount of $0 in Q2 2026.
What does pharmaceutical — segment reporting other item amount mean?
This metric aggregates miscellaneous financial items or adjustments specific to the pharmaceutical segment that do not fit into standard operating expense categories. It provides transparency into non-recurring or unique operational costs that impact the segment's profitability. Investors monitor this to identify one-time events or accounting adjustments that might distort core performance trends.